IL ‐17A‐producing CD 30 + Vδ1 T cells drive inflammation‐induced cancer progression

Author:

Kimura Yoshitaka1,Nagai Nao1,Tsunekawa Naoki1,Sato‐Matsushita Marimo2,Yoshimoto Takayuki3,Cua Daniel J.4,Iwakura Yoichiro5,Yagita Hideo6,Okada Futoshi78,Tahara Hideaki2,Saiki Ikuo9,Irimura Tatsuro1,Hayakawa Yoshihiro19

Affiliation:

1. Laboratory of Cancer Biology and Molecular Immunology Graduate School of Pharmaceutical Sciences University of Tokyo Bunkyo‐ku Tokyo Japan

2. Department of Surgery and Bioengineering Institute of Medical Science University of Tokyo Minato‐ku Tokyo Japan

3. Department of Immunoregulation Institute of Medical Science Tokyo Medical University Shinjuku‐ku Tokyo Japan

4. Pathway Biology Merck Research Laboratories Palo Alto California USA

5. Center for Animal Disease Models Research Institute for Biomedical Sciences Tokyo University of Science Noda Chiba Japan

6. Department of Immunology Juntendo University School of Medicine Bunkyo‐ku Tokyo Japan

7. Division of Pathological Biochemistry Tottori University Faculty of Medicine Yonago Tottori Japan

8. Chromosome Engineering Research Center Tottori University Yonago Tottori Japan

9. Division of Pathogenic Biochemistry Department of Bioscience Institute of Natural Medicine University of Toyama Toyama Toyama Japan

Funder

Ministry of Education, Culture, Sports, Science, and Technology

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Cited by 27 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3